Cyclosporine and Myopathy
Authors: Marc Noppen, B. Velkeniers, R. Dierckx, M. Bruyland, L. Vanhaelst
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 December 1987Cyclosporine and MyopathyM. NOPPEN, M.D., B. VELKENIERS, M.D., R. DIERCKX, M.D., M. BRUYLAND, M.D., L. VANHAELST, M.D., PH.D.M. NOPPEN, M.D.Search for more papers by this author, B. VELKENIERS, M.D.Search for more papers by this author, R. DIERCKX, M.D.Search for more papers by this author, M. BRUYLAND, M.D.Search for more papers by this author, L. VANHAELST, M.D., PH.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-107-6-945_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Graves disease with ophthalmopathy was diagnosed in a 37-year-old woman. Treatment consisted of propranolol, 20 mg three times a day, propylthiouracil, 100 mg three times a day; and plasmapheresis (three sessions over a period of 5 days; total plasma exchange, 7.5 L). According to a study protocol in our institution, this was followed by cyclosporine (Sandimmune; Sandoz Pharmaceuticals, East Hanover, New Jersey) 10 mg/kg · body weight (500 mg/d). After 3 weeks, thyroid function tests had returned to normal values, and there was a marked improvement of the ophthalmopathy on physical examination, Hertel exophthalmometry, and orbital computed...Reference1. GLYNN L. Histopathology. Clin Rheum Dis. 1984;10:53-73. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: University Hospital of the Vrije Universiteit Brussel B-1090 Brussels Belgium. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByToxic myopathiesToxic MyopathiesBeyond the jointsDrugs Causing Muscle DiseaseConnective Tissue Diseases, Vasculitis, and the Nervous SystemColchicine-induced toxicity in a heart transplant patient with chronic renal failureMyotoxicity occurring with ciclosporin in a patient with atopic dermatitisToxic MyopathiesMild electrophilic halogenation of chloropyridines using CCl4 or C2Cl6 under basic phase transfer conditionsDrug-induced and toxic myopathiesChapter 32 Toxic myopathiesAcquired MyopathiesChapter 2 Myofiber specification and survivalMuscle disorders associated with cyclosporine treatmentAcute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: possible role of the multidrug resistance transporterCase 22-1998Cellular adaptations of skeletal muscles to cyclosporineMyotonia in colchicine myoneuropathyNeuromuscular complications associated with liver transplantationAdaptation cardiovasculaire du transplanté cardiaque à l'exercice dynamiqueDRUG-RELATED MYOPATHIESPolyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin AMuscular disorders associated with cyclosporinDrug-induced myopathiesRheumatic syndromes caused by antirheumatic drugsDrug-induced myopathiesReversible cyclosporin myopathyCyclosporine: A Review and Its Specific Use in Liver TransplantationMYOPATHY AS POSSIBLE SIDE-EFFECT OF CYCLOSPORINMyopathie 1 December 1987Volume 107, Issue 6Page: 945-946KeywordsBlood plasmaBody weightThyroid Issue Published: 1 December 1987 PDF DownloadLoading ...